- Home
- ASTC vs EDSA Comparison
ASTC vs EDSA Comparison
Compare ASTC & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- EDSA
- Stock Information
- Founded
- ASTC 1984
- EDSA 2015
- Country
- ASTC United States
- EDSA Canada
- Employees
- ASTC N/A
- EDSA N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- ASTC Industrials
- EDSA Health Care
- Exchange
- ASTC Nasdaq
- EDSA Nasdaq
- Market Cap
- ASTC 17.3M
- EDSA 14.6M
- IPO Year
- ASTC 1995
- EDSA N/A
- Fundamental
- Price
- ASTC $10.17
- EDSA $4.36
- Analyst Decision
- ASTC
- EDSA Strong Buy
- Analyst Count
- ASTC 0
- EDSA 2
- Target Price
- ASTC N/A
- EDSA $39.00
- AVG Volume (30 Days)
- ASTC 55.9K
- EDSA 5.3K
- Earning Date
- ASTC 09-26-2024
- EDSA 08-09-2024
- Dividend Yield
- ASTC N/A
- EDSA N/A
- EPS Growth
- ASTC N/A
- EDSA N/A
- EPS
- ASTC N/A
- EDSA N/A
- Revenue
- ASTC $2,004,000.00
- EDSA N/A
- Revenue This Year
- ASTC N/A
- EDSA N/A
- Revenue Next Year
- ASTC N/A
- EDSA N/A
- P/E Ratio
- ASTC N/A
- EDSA N/A
- Revenue Growth
- ASTC 456.67
- EDSA N/A
- 52 Week Low
- ASTC $7.00
- EDSA $2.46
- 52 Week High
- ASTC $12.29
- EDSA $8.33
- Technical
- Relative Strength Index (RSI)
- ASTC 52.92
- EDSA 44.80
- Support Level
- ASTC $10.03
- EDSA $4.20
- Resistance Level
- ASTC $12.29
- EDSA $4.80
- Average True Range (ATR)
- ASTC 0.74
- EDSA 0.24
- MACD
- ASTC -0.08
- EDSA -0.01
- Stochastic Oscillator
- ASTC 25.09
- EDSA 29.03
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.